Invention Application
- Patent Title: QUINOLYL PHOSPHINE OXIDE COMPOUND, AND COMPOSITION AND APPLICATION THEREOF
-
Application No.: US17799234Application Date: 2021-02-08
-
Publication No.: US20230131025A1Publication Date: 2023-04-27
- Inventor: Xiangyong LIU , Changyong QIU , Mengqiang LIU , Xiaodong SONG , Qichao SHEN , Guolong DU , Haitong SHENG , Lieming DING , Jiabing WANG
- Applicant: Betta Pharmaceuticals Co., Ltd.
- Applicant Address: CN Zhejiang
- Assignee: Betta Pharmaceuticals Co., Ltd.
- Current Assignee: Betta Pharmaceuticals Co., Ltd.
- Current Assignee Address: CN Zhejiang
- Priority: CN202010094824.5 20200214,CN202110142695.7 20210202
- International Application: PCT/CN2021/075994 WO 20210208
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D215/38 ; A61P35/00 ; C07D401/14 ; C07D417/14
Abstract:
The present invention relates to a compound of formula (I), a method for using the compound as an EGFR inhibitor, and a pharmaceutical composition comprising the compound. The compound can be used for treatment, prevention or alleviation of diseases or disorders such as cancer or infection.
Information query
